We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
LGC Clinical Diagnostics


Illumina develops, manufactures and markets integrated systems for the analysis of genetic variations and biological ... read more Featured Products: More products

Download Mobile App

MIS-C Linked to Rare, Immune-Related Variants

By LabMedica International staff writers
Posted on 07 Jun 2022
Print article
Image: The NovaSeq 6000 offers deeper and broader coverage through advanced applications for a comprehensive view of the genome (Photo courtesy of Illumina)
Image: The NovaSeq 6000 offers deeper and broader coverage through advanced applications for a comprehensive view of the genome (Photo courtesy of Illumina)

Multisystem inflammatory syndrome in children (MIS-C) is a critical and potentially life-threatening complication of COVID-19 in pediatric settings. Children who were diagnosed with MIS-C tested positive for SARS-CoV-2 infection by reverse transcriptase–polymerase chain reaction (RT-PCR) or antibody testing and had fever for more than four days.

Some possible indications of the pathophysiologic mechanisms behind MIS-C have been identified. Cytokine profiling of patients with MIS-C revealed elevated inflammatory markers (IL-18 and IL-6), activation of myeloid and lymphocytic chemokines (CCL3, CCL4, and CDCP1), and dysregulation of mucosal immune markers (IL-17A, CCL20, and CCL28).

Medical Scientists at the Al Jalila Children’s Hospital (Dubai, United Arab Emirates) and their colleagues conducted a prospective, multicenter cohort study was conducted from September 1, 2020, to August 31, 2021, in the United Arab Emirates and Jordan. Forty-five patients with MIS-C and a matched control group of 25 healthy children with a confirmed SARS-CoV-2 infection status were recruited.

Whole exome sequencing was performed in the genomic laboratory. DNA was extracted from peripheral blood cells using standard DNA extraction protocols (Qiagen, Venlo, The Netherlands). After fragmentation by ultrasonication, genomic DNA was processed to generate sequencing-ready libraries of short fragments (300-400 bp) using the SureSelect kit (Agilent, Santa Clara, CA, USA). RNA baits targeting all coding regions were used to enrich for whole exome regions using the Agilent SureSelect Clinical Research Exome V2 kit. The enriched libraries underwent next-generation sequencing (2 × 150 bp) using the SP flow cell and the NovaSeq platform (Illumina, San Diego, CA, USA).

The team reported that key inflammatory markers were significantly dysregulated in all patients with MIS-C. Mucocutaneous and gastrointestinal manifestations were each reported in 36 patients (80.0%), cardiac findings were reported in 22 (48.9%), and neurologic findings were reported in 14 (31.1%). Rare, likely deleterious heterozygous variants in immune-related genes, including TLR3, TLR6, IL22RA2, IFNB1, and IFNA6, were identified in 19 patients (42.2%) of whom seven had multiple variants. There was higher enrichment of genetic variants in patients relative to controls (29 versus 3). Patients with those variants tended to have earlier disease onset, seven patients (36.8%) with genetic findings versus two (7.7%) without genetic findings were younger than 3 years at onset, and eight patients resistance to treatment (42.1%) with genetic findings versus three patients (11.5%) without genetic findings, who received two doses of intravenous immunoglobulin.

Ahmad Abou Tayoun, PhD, a clinical molecular geneticist and a senior author of the study, said, “Those pathways, which overlap with the currently characterized immunologic profile in patients with MIS-C, might represent new therapeutic targets for those patients. Patients with rare genetic variants tended to have earlier disease onset and resistance to treatment suggesting those patients can be managed differently.”

The authors concluded that the results of the study suggest that rare, likely deleterious genetic variants may contribute to MIS-C disease. This finding paves the way for additional studies with larger, diverse populations to fully characterize the genetic contribution to this new disease entity. The study was published on May 31, 2022 in the journal JAMA Network Open.

Related Links:
Al Jalila Children’s Hospital

Flocked Swab
HydraFlock and PurFlock Ultra
Gold Supplier
Semi-Automatic Coagulation Analyzer
Clot 2B
POCT Fluorescent Immunoassay Analyzer

Print article


Clinical Chem.

view channel
Image: Electrochemical cells etched by laser on wooden tongue depressor measure glucose and nitrite in saliva (Photo courtesy of Analytical Chemistry)

Biosensor-Fabricated Wooden Tongue Depressor Measures Glucose and Nitrite in Saliva

Physicians often use tongue depressors to examine a patient's mouth and throat. However, it is hard to imagine that this simple wooden tool could actively assess a patient's health. This idea has led to... Read more

Molecular Diagnostics

view channel
Image: The Geo portable testing platform integrated with the Snap collection device (Photo courtesy of ReadyGo Diagnostics)

Ultra-Portable Rapid Test Platform Offers Complete Sample-to-Answer Solution for Remote and Off-Grid Testing

An ultra-portable isothermal molecular diagnostics system integrated with a patented device which combines sample collection and processing into a single, easy-to-use disposable is set to revolutionize... Read more


view channel
Image: The Atellica HEMA 570 and 580 hematology analyzers remove workflow barriers (Photo courtesy of Siemens)

Next-Gen Hematology Analyzers Eliminate Workflow Roadblocks and Achieve Fast Throughput

Hematology testing is a critical aspect of patient care, utilized to establish a patient's health baseline, track treatment progress, or guide timely modifications to care. However, increasing constraints... Read more


view channel
Image: Newly observed anti-FSP antibodies have also been found to predict immune-related adverse events (Photo courtesy of Calviri)

First Blood-Based Biomarkers Test to Predict Treatment Response in Cancer Patients

Every year worldwide, lung cancer afflicts over two million individuals and almost the same number of people succumb to the disease. This malignancy leads the charts in cancer-related mortalities, with... Read more


view channel
Image: The rapid MTB strip test for tuberculosis can identify TB patients within two hours (Photo courtesy of Chulalongkorn University)

Rapid MTB Strip Test Detects Tuberculosis in Less Than an Hour without Special Tools

Tuberculosis (TB), a highly infectious disease, continues to pose significant challenges to public health worldwide. TB is caused by a bacterium known as "Mycobacterium tuberculosis," spreading through... Read more


view channel
Image: The UNIQO 160 (CE-IVDR) advances diagnostic analysis for autoimmune diseases (Photo courtesy of EUROIMMUN)

Novel Automated IIFT System Enables Cutting-Edge Diagnostic Analysis

A newly-launched automated indirect immunofluorescence test (IIFT) system for autoimmune disease diagnostics offers an all-in-one solution to enhance the efficiency of the complete IIFT process, comprising... Read more


view channel
Electronic biosensor uses DNA aptamers for detecting biomarkers in whole blood samples (Photo courtesy of Freepik)

Electronic Biosensor Detects Biomarkers in Whole Blood Samples without Addition of Reagents

The absence of robust, reliable, and user-friendly bioanalytical tools for early and timely diagnosis of cardiovascular diseases, particularly sudden cardiac arrest, leads to preventable deaths and imposes... Read more


view channel
Image: The global HbA1c testing devices market is expected to reach USD 2.56 billion in 2027 (Photo courtesy of Freepik)

Global Hemoglobin A1c Testing Devices Market Driven by Rising Prevalence of Diabetes

Hemoglobin A1c (HbA1c), or glycated hemoglobin, refers to hemoglobin with glucose attached. HbA1c testing devices are used for blood tests that determine average blood glucose, or blood sugar levels.... Read more
Copyright © 2000-2023 Globetech Media. All rights reserved.